A laboratory has an unromantic way of introducing itself. Before the discoveries come the dishes. Sunny Jain’s first college laboratory job included washing them and preparing Petri dishes. It is a useful opening scene for a founder’s biography: a young person learning that interesting work depends on someone doing the ordinary work properly. The glamorous part of science has excellent public relations. The washing up could use an agent.
Jain would go on to found Sun Genomics in 2016 and build the Floré brand. Along the way, he became a laboratory manager, an employer, a fundraiser and a public representative of his company. Those roles sound tidy in a biography. In practice, they ask for different skills, often on the same afternoon. A founder can finish explaining a technical question and discover that the next question concerns money, staffing or an order that needs attention.
His career is interesting for the distance between those jobs. Scientific experience gave him a place to begin. Running a company asked him to keep learning. By 2024, when he stepped away and Craig Rouskey took over as chief executive, the story had acquired something founder profiles sometimes leave out: a handoff.
The first job was washing up
Jain grew up in Iowa, mainly in Des Moines. He describes a mother who encouraged creativity and community participation, and a childhood in which he and his brother experimented with technology. The useful word is experimented. A device could be something to play with and something to improve. Figuring out how it worked was part of the entertainment.
His interest in biochemistry continued through high school. At the University of Iowa, practical laboratory work led to research in the Engelhardt lab. Graduate study followed. There is a familiar university sequence here, but an appealingly physical beginning: preparation, materials, a bench, work that someone else needs before the next stage can happen.
He earned his bachelor’s degree in 1999 and completed his master’s work in 2004. His professional biography places him at Pathway Diagnostics after graduation, then at LabCorp in 2007. These were jobs in which developing a method also meant making it usable. An elegant result is only part of the assignment when other people will depend on the process.
Seven years of making things repeatable
In 2009, Jain began work at Illumina as a laboratory manager and technical supervisor. He spent seven years there and helped establish its services laboratory. The period gave him experience with both sophisticated sequencing work and the machinery of operating a laboratory. A company’s technical promise has to survive contact with an actual working day.
His responsibilities included validation work, a site relocation and changes to payment processing. That last item earns its place in the story. The person who understands the experiment may also need to understand how the organization gets paid. Laboratories have bills. So do the people working in them. The invoice is seldom invited into the origin story, although it has a habit of arriving anyway.
This background makes his move into entrepreneurship easier to understand without making it seem inevitable. He had already worked where scientific tasks and operating tasks met. Founding added ownership of a wider problem: deciding which work to pursue, finding people to do it and keeping enough resources available for them to continue.
A company begins with other people
Jain began Sun Genomics alone. The organization soon needed skills beyond those of its founder. One early connection arrived through Twitter: Thibaut Montagne followed the company’s account, Jain connected with him, and Montagne became an early bioinformatics hire. A small online gesture turned into a working relationship.
The detail is pleasing because it gives recruitment a human scale. Before a growing company can describe its team, people have to find one another. They have to recognize a useful overlap between interest and ability. A follow is easy. Joining an early company asks for a considerably longer attention span.
The company’s early newsletter described Jain’s experience setting up and running laboratories and his interest in entrepreneurship. The combination matters. Knowing the work gives a founder one kind of credibility. Making room for colleagues gives the organization a chance to become more capable than the individual who started it.
Four months on a different clock
IndieBio brought another change of pace. Looking back in 2018, Jain said its team had pushed him to think on a larger scale and move faster. He described four months in the accelerator as a period of greater growth than the company’s preceding fourteen months. The team hired, added intellectual property and expanded its customer base.
That is his account of an early acceleration, rather than a permanent speed limit for the business. The interesting shift is in the job itself. In a laboratory, a person can spend a long time improving a method. In a startup, that work shares the calendar with recruiting, selling, fundraising and explaining why the project deserves to exist.
“IndieBio and its team challenged us to think bigger and innovate quicker.”
Sunny Jain, 2018
An accelerator compresses those demands into a short period. A founder has to describe the company clearly enough for people outside the room to understand it. Technical competence remains useful; so does the ability to make a decision before every uncertainty has politely removed itself. Uncertainty is an inconsiderate guest. It rarely knows when to leave.
What $9.25 million asks of you
In September 2020, Sun Genomics announced the close of a $9.25 million Series A financing. Pangaea Ventures led the round. The investor group also included the Orion Fund, managed by K3 Ventures, Emerging Technologies Partners, Danone Manifesto Ventures, SOSV, Human Longevity and Nascita Ventures. The announcement paired the funding with plans for expansion and new appointments.
Capital raised by Sun Genomics during Jain’s tenure as founder and CEO.
A financing round brings attention to a number. Its practical meaning lives in what happens next. The company said it would scale delivery across the United States, enter international markets and support publication work with academic partners. These are separate commitments, with separate calendars and people attached to them.
Jain’s earlier operating experience belongs beside the funding figure. Expansion requires an organization that can absorb the next task. New colleagues need responsibilities. Partners need coordination. Customers need a dependable experience. Money can buy equipment and time; it also gives a team more decisions to make about both.
A scientist learns to be seen
As Floré developed, Jain became part of its public face. Interviews and conference appearances placed him outside the laboratory, explaining the company’s work to audiences with different levels of technical familiarity. The founder’s job now included making complicated ideas intelligible without turning every conversation into a seminar.
The San Diego Business Journal included him in its 2022 SD500 publication. Its profile emphasized fundraising, team building, laboratory operations and commercialization. The selection offers a useful view of his place in the city’s business community: a scientist whose responsibilities had grown well beyond an individual experiment.
There was an international dimension, too. In a Fribourg economic-development publication, he described searching for a European partner and finding a fit with SICHH in Switzerland. A company can have a San Diego address and still require relationships elsewhere. Expansion involves finding people who can do the work with you, in a setting you have to learn.
The chair changes hands
In 2024, Jain announced that he was stepping away from Sun Genomics. Craig Rouskey would take over. August trade coverage confirmed the succession. Jain said he would continue as a customer and shareholder. It was a change in his working relationship with the company he had started eight years earlier.
His departure message made room for his wife, children, family, friends, colleagues, investors and partners. He acknowledged late nights and missed gatherings, then joked about making up for them by arriving at an event on time. The humor gave the farewell a domestic scale. A company calendar takes its hours from somewhere.
The acknowledgment also changes the portrait. The early company had begun with one founder, but its story had accumulated other people. Letting them into the closing chapter gives a more accurate sense of what had been built. A chief executive can be named on a business card. The work has many names attached to it.
Keep the route back
Jain once recalled a childhood walk through an Indian bazaar with his grandfather, who tore paper into pieces as they walked. The lesson he took from it was to remember the path that brought you somewhere. His grandfather’s advice became a line Jain kept: “Leave a trail of where you have been so you can always go back.”
For his own career, the route includes Iowa, laboratories, colleagues, a company and eventually a change of chair. It is worth keeping those stages in view. Each asks something different of a person. Preparing the work, managing it, funding it and handing it over are all parts of the biography. Sunny Jain’s founder education has room for the dishes.